Answers are grounded in this paper and cite their sources.
Cross-sectional study finds COVID-19 and depression predict menstrual dysfunction in female students, suggesting implications for health monitoring.
Objective. To determine the incidence of menstrual dysfunction depending on the «COVID status» and the level of immunization in female students of various higher educational institutions in Russia and neighboring countries during the COVID-19 pandemic, as well as to identify possible predictors of these disorders. Material and methods. An international, cross-sectional, multicenter study was conducted among female students of universities in Russia, Georgia, and Uzbekistan. Data were obtained using an online survey. The study included 1.671 students. Respondents were divided into 3 groups depending on their «COVID status» and immunization level: Group 1 — students who had had symptomatic clinically manifested novel coronavirus infection, confirmed by PCR testing, and unvaccinated (n=169); Group 2 — primarily vaccinated (n=1.310). Group 3 (control) included female students without a history of novel coronavirus infection and were not vaccinated at the time of the survey (n=192). To study the predictors of menstrual dysfunction (MD) during the novel coronavirus pandemic, two additional comparison groups were formed: the first group included respondents with changes in menstrual function (MF) (n=635), and the second group included respondents with no changes in MF (n=1036). Results. The incidence of MD was 38%. The most common predictor was an extended menstrual cycle, noted in 25% of those with novel coronavirus infection and in 22.4% of the control group. The second most common predictor (20.2%) was increased menstrual pain, which was more pronounced in the subgroup of those with novel coronavirus infection (20.2%). In third place is an increase in premenstrual symptoms (PMS), without significant differences in the survey groups. Fourth place (11.3%) is an increase in the intensity of menstrual blood loss, which was significantly more common after COVID-19. The most significant predictors of MFD during the pandemic were identified as follows: a history of COVID-19 with symptoms confirmed by PCR testing (odds ratio — OR — 1.7; 95% confidence interval — CI — 1.2-2.3), moderate to severe depression (OR — 1.6; 95% CI — 1.2–2.1), a history of diseases associated with MFD (OR — 1.7; 95% CI — 1.2–2.5), MFD before the pandemic (OR — 1.3; 95% CI — 1.1–1.5). Primary vaccination was a protective factor (OR 0.8; 95% CI 0.6–0.9). Conclusion. During the COVID-19 pandemic, the proportion of female students with MFD was 38.0%. One in four female students who had COVID-19 and one in five female students in the control group reported an extended menstrual cycle (MC). Increased menstrual pain and intensity, as well as premenstrual syndrom, were observed in all study groups. Meanwhile, more painful and heavy menstrual periods were observed in female students who had COVID-19. The most prognostically significant predictors of MFD were a previous novel coronavirus infection with symptoms confirmed by PCR testing, moderate to severe depression, and a history of illnesses associated with MFD.
No takes yet. Share an insight, caveat, or question.
Горбачева et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: